US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

CNS/Neurology: market research reports

RSS Feeds

CNS/Neurology market research reports and industry analysis

1  2    4    6  7  8  9  10  
Market Highlights: Spain Migraine – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, migraine drugs market share, migraine drugs sales estimates, migraine drugs sales forecast, and migraine late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: Japan Migraine – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, migraine drugs market share, migraine drugs sales estimates, migraine drugs sales forecast, and migraine late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: Spain Glioblastoma – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, glioblastoma drugs market share, glioblastoma drugs sales estimates, glioblastoma drugs sales forecast, and glioblastoma late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: Europe Migraine – 2014
5/1/2014 | published by: Fore Pharma
... research includes Europe (Germany, France, Italy, Spain, and UK) migraine market size estimates for 2013, market share forecast for six years to 2019, migraine drugs market share, migraine drugs sales estimates, migraine drugs sales forecast, ...  |  read more...
USD 2,800
Market Highlights: Spain Bipolar Disorder – 2014
5/1/2014 | published by: Fore Pharma
... research includes Spain bipolar disorder market size estimates for 2013, market share forecast for six years to 2019, bipolar disorder drugs market share, bipolar disorder drugs sales estimates, bipolar disorder drugs sales forecast, and bipolar ...  |  read more...
USD 990
Market Highlights: UK Glioblastoma – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, glioblastoma drugs market share, glioblastoma drugs sales estimates, glioblastoma drugs sales forecast, and glioblastoma late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: Italy Bipolar Disorder – 2014
5/1/2014 | published by: Fore Pharma
... research includes Italy bipolar disorder market size estimates for 2013, market share forecast for six years to 2019, bipolar disorder drugs market share, bipolar disorder drugs sales estimates, bipolar disorder drugs sales forecast, and bipolar ...  |  read more...
USD 990
Market Highlights: US Bipolar Disorder – 2014
5/1/2014 | published by: Fore Pharma
... US. The research includes the US bipolar disorder market size estimates for 2013, market share forecast for six years to 2019, bipolar disorder drugs market share, bipolar disorder drugs sales estimates, bipolar disorder drugs sales ...  |  read more...
USD 990
Market Highlights: US Glioblastoma – 2014
5/1/2014 | published by: Fore Pharma
... the US glioblastoma market size estimates for 2013, market share forecast for six years to 2019, glioblastoma drugs market share, glioblastoma drugs sales estimates, glioblastoma drugs sales forecast, and glioblastoma late stage pipeline products.This research ...  |  read more...
USD 990
Market Highlights: Europe Glioblastoma – 2014
5/1/2014 | published by: Fore Pharma
... research includes Europe (Germany, France, Italy, Spain, and UK) glioblastoma market size estimates for 2013, market share forecast for six years to 2019, glioblastoma drugs market share, glioblastoma drugs sales estimates, glioblastoma drugs sales forecast, ...  |  read more...
USD 2,800
Update: Schizophrenia Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing ...  |  read more...
USD 590
Update: Glioblastoma Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing ...  |  read more...
USD 590
Update: Amyotrophic Lateral Sclerosis Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... It covers emerging therapies for Amyotrophic Lateral Sclerosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating ...  |  read more...
USD 590
Market Highlights: Italy Attention Deficit Hyperactivity Disorder – 2014
5/1/2014 | published by: Fore Pharma
... hyperactivity disorder drug sales forecast in Italy. The research includes Italy attention deficit hyperactivity disorder market size estimates for 2013, market share forecast for six years to 2019, attention deficit hyperactivity disorder drugs market share, ...  |  read more...
USD 990
Market Highlights: France Schizophrenia – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, schizophrenia drugs market share, schizophrenia drugs sales estimates, schizophrenia drugs sales forecast, and schizophrenia late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: US Schizophrenia – 2014
5/1/2014 | published by: Fore Pharma
... the US schizophrenia market size estimates for 2013, market share forecast for six years to 2019, schizophrenia drugs market share, schizophrenia drugs sales estimates, schizophrenia drugs sales forecast, and schizophrenia late stage pipeline products.This research ...  |  read more...
USD 990
Market Highlights: UK Depression – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, depression drugs market share, depression drugs sales estimates, depression drugs sales forecast, and depression late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: Spain Attention Deficit Hyperactivity Disorder – 2014
5/1/2014 | published by: Fore Pharma
... hyperactivity disorder drug sales forecast in Spain. The research includes Spain attention deficit hyperactivity disorder market size estimates for 2013, market share forecast for six years to 2019, attention deficit hyperactivity disorder drugs market share, ...  |  read more...
USD 990
Market Highlights: France Glioblastoma – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, glioblastoma drugs market share, glioblastoma drugs sales estimates, glioblastoma drugs sales forecast, and glioblastoma late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Update: Attention Deficit Hyperactivity Disorder Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... Hyperactivity Disorder market. It covers emerging therapies for Attention Deficit Hyperactivity Disorder in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking ...  |  read more...
USD 590
Update: Bipolar Disorder Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... therapies for Bipolar Disorder in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development ...  |  read more...
USD 590
Market Highlights: Italy Migraine – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, migraine drugs market share, migraine drugs sales estimates, migraine drugs sales forecast, and migraine late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: Europe Bipolar Disorder – 2014
5/1/2014 | published by: Fore Pharma
... Spain, and UK. The research includes Europe (Germany, France, Italy, Spain, and UK) bipolar disorder market size estimates for 2013, market share forecast for six years to 2019, bipolar disorder drugs market share, bipolar disorder ...  |  read more...
USD 2,800
Market Highlights: UK Attention Deficit Hyperactivity Disorder – 2014
5/1/2014 | published by: Fore Pharma
... hyperactivity disorder drug sales forecast in UK. The research includes UK attention deficit hyperactivity disorder market size estimates for 2013, market share forecast for six years to 2019, attention deficit hyperactivity disorder drugs market share, ...  |  read more...
USD 990
Market Highlights: US Attention Deficit Hyperactivity Disorder – 2014
5/1/2014 | published by: Fore Pharma
... deficit hyperactivity disorder drug sales forecast in the US. The research includes the US attention deficit hyperactivity disorder market size estimates for 2013, market share forecast for six years to 2019, attention deficit hyperactivity disorder ...  |  read more...
USD 990
1  2    4    6  7  8  9  10  
 
Our Clients